Damiano, a professor at Boston University and the chief executive of a promising start-up called Beta Bionics, was there to support a new generation of continuous glucose monitoring technology – part ...

Irvine-based Beta Bionics, which recently went public, saw two-year revenue increase more than eight-fold to $103.2 million.

Advanced report intelligence delivers actionable guidance to improve outcomes for people using the iLet Bionic PancreasIRVINE, Calif., March 31, 2026 (GLOBE NEWSWIRE) -- Beta Bionics today announced ...

Beta Bionics Inc. was born out of a father’s desire to improve his son’s quality of life following a diabetes diagnosis. Today, 10 years after its founding, it’s now a publicly traded company. The ...

Shares of Beta Bionics fell after the maker of insulin-delivery systems shared preliminary data for new patient starts that were below expectations. The stock slipped 36%, to $20.5, on Friday. Over ...

Jan 22 (Reuters) - Insulin delivery device maker Beta Bionics said on Wednesday it was targeting a valuation of as much as $615.9 million in its initial public offering in the United States, ...

Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its first quarter 2026 financial results ...

Sub-Q Bionics, a medical device company developing next-generation solutions to improve care for patients living with lymphedema, today announced the successful close of its $1.5 million pre-seed ...

View Ekso Bionics Holdings, Inc. EKSO stock quote prices, financial information, real-time forecasts, and company news from CNN.